STAT+: Inside Moderna and Merck’s cancer vaccine triumph
Moderna and Merck's wild gambit on a cancer vaccine appears to have worked, despite big doubts, logistical challenges, and pandemic-era complications.
STAT
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from STAT.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
STAT (www.statnews.com), a Tier B publisher, filed this report on . CurrentWire published this page 40 minutes later, on .
Signal breakdown
CurrentWire ranked this story 61.6 of 100 in the snapshot this page was rendered from.
- Freshness
- 32.1 of 35
- Source authority
- 14 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 3.5 of 10
- Story prominence
- 8 of 10
- Velocity
- 0 of 5
Strongest signal: freshness, 32.1 of 35. How each signal is calculated.
Filed under Health · International · News. Topics extracted from this report, with other live CurrentWire stories mentioning each: Inside Moderna (none).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.